The board has recommended a dividend of 120 per cent i.e. Rs 6 per share for the financial year ended March 31, 2019.
“There was a good performance, both in the hospitals and in the pharmacy division. The overall strategy of continuing to focus on improving asset utilisation, superior margin profile through case mix and quality of revenue, along with optimisation in costs. This approach is paying off with the healthcare services EBITDA growing by 21 per cent YoY to Rs 210 crore,” Apollo Hospitals said in a regulatory filing.
As on March 31, 2019, Apollo Hospitals had 7,200 plus operating beds across the network (excluding Apollo Health & Lifestyle & managed beds), out of which,13 were new hospitals with 1,790 operating beds. The new hospitals are expected to see increase in volumes and utilisation going forward.
At 11:09 am, Apollo Hospitals was up 8 per cent at Rs 1,338 on the BSE.
The stock was trading close to its 52-week high level of Rs 1,387 touched on January 21, 2019. The trading volumes on the counter nearly doubled with a combined 2.06 million shares changing hands on the NSE